These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12641876)

  • 1. Traditional cardiac risk factors in individuals with chronic kidney disease.
    Uhlig K; Levey AS; Sarnak MJ
    Semin Dial; 2003; 16(2):118-27. PubMed ID: 12641876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure.
    Foley RN
    Semin Dial; 2003; 16(2):111-7. PubMed ID: 12641874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?
    Gregg LP; Hedayati SS
    Am J Kidney Dis; 2018 Nov; 72(5):728-744. PubMed ID: 29478869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular disease in kidney transplantation].
    Marcén R; Pascual J
    Nefrologia; 2001; 21(2):104-14. PubMed ID: 11464644
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. At which stage of chronic kidney disease should dyslipidemia be treated?
    Krane V; Wanner C
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):176-7. PubMed ID: 16932418
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing dyslipidemia in chronic kidney disease.
    Weiner DE; Sarnak MJ
    J Gen Intern Med; 2004 Oct; 19(10):1045-52. PubMed ID: 15482558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
    Kasiske B; Cosio FG; Beto J; Bolton K; Chavers BM; Grimm R; Levin A; Masri B; Parekh R; Wanner C; Wheeler DC; Wilson PW;
    Am J Transplant; 2004; 4 Suppl 7():13-53. PubMed ID: 15027968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in patients with chronic kidney disease. A clinical review.
    Kaisar M; Isbel N; Johnson DW
    Minerva Urol Nefrol; 2007 Sep; 59(3):281-97. PubMed ID: 17912225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use in patients with diabetes and kidney disease: the Japanese experience.
    Koya D; Campese VM
    J Atheroscler Thromb; 2013; 20(5):407-24. PubMed ID: 23518468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is chronic kidney disease a cardiovascular disease risk factor?
    Culleton BF; Hemmelgarn BR
    Semin Dial; 2003; 16(2):95-100. PubMed ID: 12641871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):753-9. PubMed ID: 15949381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.